BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28373691)

  • 1. Blocking human fear memory with the matrix metalloproteinase inhibitor doxycycline.
    Bach DR; Tzovara A; Vunder J
    Mol Psychiatry; 2018 Jul; 23(7):1584-1589. PubMed ID: 28373691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Threat Memory Reminder Under Matrix Metalloproteinase 9 Inhibitor Doxycycline Globally Reduces Subsequent Memory Plasticity.
    Bach DR; Näf M; Deutschmann M; Tyagarajan SK; Quednow BB
    J Neurosci; 2019 Nov; 39(47):9424-9434. PubMed ID: 31615840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the Matrix Metalloproteinase Inhibitor Doxycycline on Human Trace Fear Memory.
    Wehrli JM; Xia Y; Offenhammer B; Kleim B; Müller D; Bach DR
    eNeuro; 2023 Feb; 10(2):. PubMed ID: 36759188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of doxycycline on human contextual fear memory.
    Wehrli JM; Xia Y; Abivardi A; Kleim B; Bach DR
    Psychopharmacology (Berl); 2024 May; 241(5):1065-1077. PubMed ID: 38334789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuating human fear memory retention with minocycline: a randomized placebo-controlled trial.
    Xia Y; Wehrli J; Abivardi A; Hostiuc M; Kleim B; Bach DR
    Transl Psychiatry; 2024 Jan; 14(1):28. PubMed ID: 38233395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortisol administration after extinction in a fear-conditioning paradigm with traumatic film clips prevents return of fear.
    Brueckner AH; Lass-Hennemann J; Wilhelm FH; Ferreira de Sá DS; Michael T
    Transl Psychiatry; 2019 Apr; 9(1):128. PubMed ID: 30962423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infralimbic cortex activity is required for the expression but not the acquisition of conditioned safety.
    Kreutzmann JC; Jovanovic T; Fendt M
    Psychopharmacology (Berl); 2020 Jul; 237(7):2161-2172. PubMed ID: 32363439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of intranasal oxytocin treatment on conditioned fear extinction and recall in a healthy human sample.
    Acheson D; Feifel D; de Wilde S; McKinney R; Lohr J; Risbrough V
    Psychopharmacology (Berl); 2013 Sep; 229(1):199-208. PubMed ID: 23644911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immediate pre-learning stress enhances baseline startle response and fear acquisition in a fear-potentiated startle paradigm.
    Riggenbach MR; Weiser JN; Mosley BE; Hipskind JJ; Wireman LE; Hess KL; Duffy TJ; Handel JK; Kaschalk MG; Reneau KE; Rorabaugh BR; Norrholm SD; Jovanovic T; Zoladz PR
    Behav Brain Res; 2019 Oct; 371():111980. PubMed ID: 31145979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fear-potentiated startle in rats.
    Davis M
    Curr Protoc Neurosci; 2001 May; Chapter 8():Unit 8.11A. PubMed ID: 18428539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed effects of cortisol enhance fear memory of trace conditioning.
    Cornelisse S; van Ast VA; Joëls M; Kindt M
    Psychoneuroendocrinology; 2014 Feb; 40():257-68. PubMed ID: 24485497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amphetamine injections into the nucleus accumbens affect neither acquisition/expression of conditioned fear nor baseline startle response.
    Schwienbacher I; Fendt M; Schnitzler HU
    Exp Brain Res; 2005 Jan; 160(4):538-44. PubMed ID: 15650891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-trauma Methylphenidate in rats reduces PTSD-like reactions one month later.
    Ritov G; Richter-Levin G
    Transl Psychiatry; 2017 Jan; 7(1):e1000. PubMed ID: 28072410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implicit but not explicit extinction to threat-conditioned stimulus prevents spontaneous recovery of threat-potentiated startle responses in humans.
    Oyarzún JP; Càmara E; Kouider S; Fuentemilla L; de Diego-Balaguer R
    Brain Behav; 2019 Jan; 9(1):e01157. PubMed ID: 30516021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fear-potentiated startle processing in humans: Parallel fMRI and orbicularis EMG assessment during cue conditioning and extinction.
    Lindner K; Neubert J; Pfannmöller J; Lotze M; Hamm AO; Wendt J
    Int J Psychophysiol; 2015 Dec; 98(3 Pt 2):535-45. PubMed ID: 25725377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revaluing the Role of vmPFC in the Acquisition of Pavlovian Threat Conditioning in Humans.
    Battaglia S; Garofalo S; di Pellegrino G; Starita F
    J Neurosci; 2020 Oct; 40(44):8491-8500. PubMed ID: 33020217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-amygdala infusion of the N-methyl-D-aspartate receptor antagonist AP5 blocks acquisition but not expression of fear-potentiated startle to an auditory conditioned stimulus.
    Campeau S; Miserendino MJ; Davis M
    Behav Neurosci; 1992 Jun; 106(3):569-574. PubMed ID: 1352104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of matrix metalloproteinase activity disrupts reconsolidation but not consolidation of a fear memory.
    Brown TE; Wilson AR; Cocking DL; Sorg BA
    Neurobiol Learn Mem; 2009 Jan; 91(1):66-72. PubMed ID: 18824238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological analysis of fear-potentiated startle.
    Davis M
    Braz J Med Biol Res; 1993 Mar; 26(3):235-60. PubMed ID: 8257926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoid modulation of prefrontal-limbic activation during fear extinction learning and recall in humans.
    Rabinak CA; Angstadt M; Lyons M; Mori S; Milad MR; Liberzon I; Phan KL
    Neurobiol Learn Mem; 2014 Sep; 113():125-34. PubMed ID: 24055595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.